APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

AI and Machine Learning in Genomics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI and Machine Learning in Genomics Market Outlook and Growth Opportunities 2026

Report ID 17443078053 July 2026190 pages

Choose your research edition.

Industry ResearchAI and Machine Learning in Genomics Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal AI and Machine Learning in Genomics Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI and Machine Learning in Genomics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI and Machine Learning in Genomics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal AI and Machine Learning in Genomics Market Analysis and Forecast 2026-2032179 pages · $4,950 USD

Market perspective

The global AI and Machine Learning in Genomics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI and Machine Learning in Genomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI and Machine Learning in Genomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI and Machine Learning in Genomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI and Machine Learning in Genomics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI and Machine Learning in Genomics market include Sophia Genetics, BenevolentAI, Illumina, Inc., Thermo Fisher Scientific Inc., Mellanox Technologies, Microsoft Corporation, Data4Cure, Inc, Freenome Holdings, Inc and Deep Genomics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI and Machine Learning in Genomics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI and Machine Learning in Genomics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI and Machine Learning in Genomics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI and Machine Learning in Genomics market.

AI and Machine Learning in Genomics Segment by Company

Sophia Genetics

BenevolentAI

Illumina, Inc.

Thermo Fisher Scientific Inc.

Mellanox Technologies

Microsoft Corporation

Data4Cure, Inc

Freenome Holdings, Inc

Deep Genomics

IBM Corporation

AI and Machine Learning in Genomics Segment by Type

Machine Learning

Computer Vision

AI and Machine Learning in Genomics Segment by Application

Drug Discovery and Development

Precision Medicine

Diagnostics

Other

AI and Machine Learning in Genomics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI and Machine Learning in Genomics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI and Machine Learning in Genomics key companies, revenue, market share, and recent developments.

3. To split the AI and Machine Learning in Genomics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI and Machine Learning in Genomics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI and Machine Learning in Genomics significant trends, drivers, influence factors in global and regions.

6. To analyze AI and Machine Learning in Genomics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI and Machine Learning in Genomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI and Machine Learning in Genomics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI and Machine Learning in Genomics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI and Machine Learning in Genomics industry.

Chapter 3: Detailed analysis of AI and Machine Learning in Genomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI and Machine Learning in Genomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI and Machine Learning in Genomics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI and Machine Learning in Genomics Industry Trends Table 2. AI and Machine Learning in Genomics Industry Drivers Table 3. AI and Machine Learning in Genomics Industry Opportunities and Challenges Table 4. AI and Machine Learning in Genomics Industry Restraints Table 5. Global AI and Machine Learning in Genomics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI and Machine Learning in Genomics Revenue Share by Company (2021-2026) Table 7. Global AI and Machine Learning in Genomics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI and Machine Learning in Genomics Key Company Manufacturing Base & Headquarters Table 9. Global AI and Machine Learning in Genomics Company, Product Type & Application Table 10. Global AI and Machine Learning in Genomics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI and Machine Learning in Genomics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Machine Learning Table 15. Significant Companies of Computer Vision Table 16. Global AI and Machine Learning in Genomics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI and Machine Learning in Genomics Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI and Machine Learning in Genomics Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI and Machine Learning in Genomics Sales Value Share by Type (2021-2026) Table 20. Global AI and Machine Learning in Genomics Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Drug Discovery and Development Table 22. Significant Companies of Precision Medicine Table 23. Significant Companies of Diagnostics Table 24. Significant Companies of Other Table 25. Global AI and Machine Learning in Genomics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI and Machine Learning in Genomics Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global AI and Machine Learning in Genomics Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global AI and Machine Learning in Genomics Sales Value Share by Application (2021-2026) Table 29. Global AI and Machine Learning in Genomics Sales Value Share by Application (2027-2032) Table 30. Global AI and Machine Learning in Genomics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI and Machine Learning in Genomics Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global AI and Machine Learning in Genomics Sales Value Share by Region (2021-2026) Table 33. Global AI and Machine Learning in Genomics Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global AI and Machine Learning in Genomics Sales Value Share by Region (2027-2032) Table 35. Global AI and Machine Learning in Genomics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI and Machine Learning in Genomics Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global AI and Machine Learning in Genomics Sales Value Market Share by Country (2021-2026) Table 38. Global AI and Machine Learning in Genomics Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global AI and Machine Learning in Genomics Sales Value Market Share by Country (2027-2032) Table 40. Sophia Genetics Company Information Table 41. Sophia Genetics Business Overview Table 42. Sophia Genetics AI and Machine Learning in Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Sophia Genetics AI and Machine Learning in Genomics Product Portfolio Table 44. Sophia Genetics Recent Development Table 45. BenevolentAI Company Information Table 46. BenevolentAI Business Overview Table 47. BenevolentAI AI and Machine Learning in Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. BenevolentAI AI and Machine Learning in Genomics Product Portfolio Table 49. BenevolentAI Recent Development Table 50. Illumina, Inc. Company Information Table 51. Illumina, Inc. Business Overview Table 52. Illumina, Inc. AI and Machine Learning in Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Illumina, Inc. AI and Machine Learning in Genomics Product Portfolio Table 54. Illumina, Inc. Recent Development Table 55. Thermo Fisher Scientific Inc. Company Information Table 56. Thermo Fisher Scientific Inc. Business Overview Table 57. Thermo Fisher Scientific Inc. AI and Machine Learning in Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Thermo Fisher Scientific Inc. AI and Machine Learning in Genomics Product Portfolio Table 59. Thermo Fisher Scientific Inc. Recent Development Table 60. Mellanox Technologies Company Information Table 61. Mellanox Technologies Business Overview Table 62. Mellanox Technologies AI and Machine Learning in Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Mellanox Technologies AI and Machine Learning in Genomics Product Portfolio Table 64. Mellanox Technologies Recent Development Table 65. Microsoft Corporation Company Information Table 66. Microsoft Corporation Business Overview Table 67. Microsoft Corporation AI and Machine Learning in Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Microsoft Corporation AI and Machine Learning in Genomics Product Portfolio Table 69. Microsoft Corporation Recent Development Table 70. Data4Cure, Inc Company Information Table 71. Data4Cure, Inc Business Overview Table 72. Data4Cure, Inc AI and Machine Learning in Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Data4Cure, Inc AI and Machine Learning in Genomics Product Portfolio Table 74. Data4Cure, Inc Recent Development Table 75. Freenome Holdings, Inc Company Information Table 76. Freenome Holdings, Inc Business Overview Table 77. Freenome Holdings, Inc AI and Machine Learning in Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Freenome Holdings, Inc AI and Machine Learning in Genomics Product Portfolio Table 79. Freenome Holdings, Inc Recent Development Table 80. Deep Genomics Company Information Table 81. Deep Genomics Business Overview Table 82. Deep Genomics AI and Machine Learning in Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Deep Genomics AI and Machine Learning in Genomics Product Portfolio Table 84. Deep Genomics Recent Development Table 85. IBM Corporation Company Information Table 86. IBM Corporation Business Overview Table 87. IBM Corporation AI and Machine Learning in Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. IBM Corporation AI and Machine Learning in Genomics Product Portfolio Table 89. IBM Corporation Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. AI and Machine Learning in Genomics Product Image Figure 2. Global AI and Machine Learning in Genomics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI and Machine Learning in Genomics Market Size (2021-2032) & (US$ Million) Figure 4. Global AI and Machine Learning in Genomics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Machine Learning Image Figure 8. Computer Vision Image Figure 9. Global AI and Machine Learning in Genomics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI and Machine Learning in Genomics Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI and Machine Learning in Genomics Sales Value Share by Type (2021-2032) Figure 12. Drug Discovery and Development Image Figure 13. Precision Medicine Image Figure 14. Diagnostics Image Figure 15. Other Image Figure 16. Global AI and Machine Learning in Genomics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI and Machine Learning in Genomics Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global AI and Machine Learning in Genomics Sales Value Share by Application (2021-2032) Figure 19. Global AI and Machine Learning in Genomics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global AI and Machine Learning in Genomics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America AI and Machine Learning in Genomics Sales Value (2021-2032) & (US$ Million) Figure 22. North America AI and Machine Learning in Genomics Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe AI and Machine Learning in Genomics Sales Value (2021-2032) & (US$ Million) Figure 24. Europe AI and Machine Learning in Genomics Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific AI and Machine Learning in Genomics Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific AI and Machine Learning in Genomics Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America AI and Machine Learning in Genomics Sales Value (2021-2032) & (US$ Million) Figure 28. South America AI and Machine Learning in Genomics Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa AI and Machine Learning in Genomics Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa AI and Machine Learning in Genomics Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Machine Learning
  • Computer Vision
Applications
  • Drug Discovery and Development
  • Precision Medicine
  • Diagnostics
  • Other
Companies covered
  • Sophia Genetics
  • BenevolentAI
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Mellanox Technologies
  • Microsoft Corporation
  • Data4Cure, Inc
  • Freenome Holdings, Inc
  • Deep Genomics
  • IBM Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI and Machine Learning in Genomics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI and Machine Learning in Genomics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI and Machine Learning in Genomics Market Dynamics
  1. 2.1 AI and Machine Learning in Genomics Industry Trends
  2. 2.2 AI and Machine Learning in Genomics Industry Drivers
  3. 2.3 AI and Machine Learning in Genomics Industry Opportunities and Challenges
  4. 2.4 AI and Machine Learning in Genomics Industry Restraints
3 AI and Machine Learning in Genomics Market by Company
  1. 3.1 Global AI and Machine Learning in Genomics Company Revenue Ranking in 2025
  2. 3.2 Global AI and Machine Learning in Genomics Revenue by Company (2021-2026)
  3. 3.3 Global AI and Machine Learning in Genomics Company Ranking (2024-2026)
  4. 3.4 Global AI and Machine Learning in Genomics Company Manufacturing Base and Headquarters
  5. 3.5 Global AI and Machine Learning in Genomics Company Product Type and Application
  6. 3.6 Global AI and Machine Learning in Genomics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI and Machine Learning in Genomics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI and Machine Learning in Genomics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI and Machine Learning in Genomics Market by Type
  1. 4.1 AI and Machine Learning in Genomics Type Introduction
  2. 4.1.1 Machine Learning
  3. 4.1.2 Computer Vision
  4. 4.2 Global AI and Machine Learning in Genomics Sales Value by Type
  5. 4.2.1 Global AI and Machine Learning in Genomics Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI and Machine Learning in Genomics Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI and Machine Learning in Genomics Sales Value Share by Type (2021-2032)
5 AI and Machine Learning in Genomics Market by Application
  1. 5.1 AI and Machine Learning in Genomics Application Introduction
  2. 5.1.1 Drug Discovery and Development
  3. 5.1.2 Precision Medicine
  4. 5.1.3 Diagnostics
  5. 5.1.4 Other
  6. 5.2 Global AI and Machine Learning in Genomics Sales Value by Application
  7. 5.2.1 Global AI and Machine Learning in Genomics Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global AI and Machine Learning in Genomics Sales Value by Application (2021-2032)
  9. 5.2.3 Global AI and Machine Learning in Genomics Sales Value Share by Application (2021-2032)
6 AI and Machine Learning in Genomics Regional Value Analysis
  1. 6.1 Global AI and Machine Learning in Genomics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI and Machine Learning in Genomics Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI and Machine Learning in Genomics Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI and Machine Learning in Genomics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI and Machine Learning in Genomics Sales Value (2021-2032)
  7. 6.3.2 North America AI and Machine Learning in Genomics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI and Machine Learning in Genomics Sales Value (2021-2032)
  10. 6.4.2 Europe AI and Machine Learning in Genomics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI and Machine Learning in Genomics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI and Machine Learning in Genomics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI and Machine Learning in Genomics Sales Value (2021-2032)
  16. 6.6.2 South America AI and Machine Learning in Genomics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI and Machine Learning in Genomics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI and Machine Learning in Genomics Sales Value Share by Country, 2025 VS 2032
7 AI and Machine Learning in Genomics Country-level Value Analysis
  1. 7.1 Global AI and Machine Learning in Genomics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI and Machine Learning in Genomics Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI and Machine Learning in Genomics Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI and Machine Learning in Genomics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI and Machine Learning in Genomics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI and Machine Learning in Genomics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI and Machine Learning in Genomics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sophia Genetics
  2. 8.1.1 Sophia Genetics Company Information
  3. 8.1.2 Sophia Genetics Business Overview
  4. 8.1.3 Sophia Genetics AI and Machine Learning in Genomics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sophia Genetics AI and Machine Learning in Genomics Product Portfolio
  6. 8.1.5 Sophia Genetics Recent Developments
  7. 8.2 BenevolentAI
  8. 8.2.1 BenevolentAI Company Information
  9. 8.2.2 BenevolentAI Business Overview
  10. 8.2.3 BenevolentAI AI and Machine Learning in Genomics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BenevolentAI AI and Machine Learning in Genomics Product Portfolio
  12. 8.2.5 BenevolentAI Recent Developments
  13. 8.3 Illumina, Inc.
  14. 8.3.1 Illumina, Inc. Company Information
  15. 8.3.2 Illumina, Inc. Business Overview
  16. 8.3.3 Illumina, Inc. AI and Machine Learning in Genomics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Illumina, Inc. AI and Machine Learning in Genomics Product Portfolio
  18. 8.3.5 Illumina, Inc. Recent Developments
  19. 8.4 Thermo Fisher Scientific Inc.
  20. 8.4.1 Thermo Fisher Scientific Inc. Company Information
  21. 8.4.2 Thermo Fisher Scientific Inc. Business Overview
  22. 8.4.3 Thermo Fisher Scientific Inc. AI and Machine Learning in Genomics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Scientific Inc. AI and Machine Learning in Genomics Product Portfolio
  24. 8.4.5 Thermo Fisher Scientific Inc. Recent Developments
  25. 8.5 Mellanox Technologies
  26. 8.5.1 Mellanox Technologies Company Information
  27. 8.5.2 Mellanox Technologies Business Overview
  28. 8.5.3 Mellanox Technologies AI and Machine Learning in Genomics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mellanox Technologies AI and Machine Learning in Genomics Product Portfolio
  30. 8.5.5 Mellanox Technologies Recent Developments
  31. 8.6 Microsoft Corporation
  32. 8.6.1 Microsoft Corporation Company Information
  33. 8.6.2 Microsoft Corporation Business Overview
  34. 8.6.3 Microsoft Corporation AI and Machine Learning in Genomics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Microsoft Corporation AI and Machine Learning in Genomics Product Portfolio
  36. 8.6.5 Microsoft Corporation Recent Developments
  37. 8.7 Data4Cure, Inc
  38. 8.7.1 Data4Cure, Inc Company Information
  39. 8.7.2 Data4Cure, Inc Business Overview
  40. 8.7.3 Data4Cure, Inc AI and Machine Learning in Genomics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Data4Cure, Inc AI and Machine Learning in Genomics Product Portfolio
  42. 8.7.5 Data4Cure, Inc Recent Developments
  43. 8.8 Freenome Holdings, Inc
  44. 8.8.1 Freenome Holdings, Inc Company Information
  45. 8.8.2 Freenome Holdings, Inc Business Overview
  46. 8.8.3 Freenome Holdings, Inc AI and Machine Learning in Genomics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Freenome Holdings, Inc AI and Machine Learning in Genomics Product Portfolio
  48. 8.8.5 Freenome Holdings, Inc Recent Developments
  49. 8.9 Deep Genomics
  50. 8.9.1 Deep Genomics Company Information
  51. 8.9.2 Deep Genomics Business Overview
  52. 8.9.3 Deep Genomics AI and Machine Learning in Genomics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Deep Genomics AI and Machine Learning in Genomics Product Portfolio
  54. 8.9.5 Deep Genomics Recent Developments
  55. 8.10 IBM Corporation
  56. 8.10.1 IBM Corporation Company Information
  57. 8.10.2 IBM Corporation Business Overview
  58. 8.10.3 IBM Corporation AI and Machine Learning in Genomics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 IBM Corporation AI and Machine Learning in Genomics Product Portfolio
  60. 8.10.5 IBM Corporation Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst